{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:21:01Z","timestamp":1792696861772,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.atherosclerosis.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T03:20:54Z","timestamp":1476069654000},"page":"282-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"special_numbering":"C","title":["Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause"],"prefix":"10.1016","volume":"254","author":[{"given":"Roger A.","family":"Lobo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Pickar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy J.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard N.","family":"Hodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0091-7435(91)90006-P","article-title":"Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence","volume":"20","author":"Stampfer","year":"1991","journal-title":"Prev. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib2","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199706193362501","article-title":"Postmenopausal hormone therapy and mortality","volume":"336","author":"Grodstein","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jama.279.9.688","article-title":"Estrogen therapy in postmenopausal women: effects on cognitive function and dementia","volume":"279","author":"Yaffe","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archinte.1991.00400010095012","article-title":"Decreased mortality in users of estrogen replacement therapy","volume":"151","author":"Henderson","year":"1991","journal-title":"Arch. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib5","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","article-title":"Hormone therapy to prevent disease and prolong life in postmenopausal women","volume":"117","author":"Grady","year":"1992","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib6","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.7326\/0003-4819-117-12-1038","article-title":"Guidelines for counseling postmenopausal women about preventive hormone therapy","volume":"117","author":"American College of Physicians","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1471-0528.2002.01544.x","article-title":"A\u00a0study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study","volume":"109","author":"Clarke","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women\u2019s Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/13697137.2014.933411","article-title":"Prevention of diseases after menopause","volume":"17","author":"Lobo","year":"2014","journal-title":"Climacteric"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0015-0282(16)60481-8","article-title":"Too much of a good thing? Use of progestogens in the menopause: an international consensus statement","volume":"51","author":"Lobo","year":"1989","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00007611-200295080-00004","article-title":"NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk and lack of overall benefit","volume":"95","year":"2002","journal-title":"South Med. J."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2009.05.033","article-title":"Coronary heart disease and menopause management: the swinging pendulum of HRT","volume":"207","author":"Stevenson","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib15","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2015-1864","article-title":"Increased cardiovascular mortality risk in women discontinuing postmenopausal hormone therapy","volume":"100","author":"Mikkola","year":"2015","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/gme.0b013e31817b816e","article-title":"Trend in incidence of osteoporosis-related fractures among 40 to 69 year old women: analysis of a large insurance claims database, 2000-2005","volume":"16","author":"Islam","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib17","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/gme.0b013e31821b01c7","article-title":"Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization","volume":"18","author":"Karim","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib18","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2105\/AJPH.2013.301295","article-title":"The mortality toll of estrogen avoidance: an analysis of excess deaths among hysterectomized women age 50 to 59","volume":"103","author":"Sarrel","year":"2013","journal-title":"Am. J. Public Health"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2016.10.005_bib19","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","article-title":"The decrease in incidence of breast cancer in the United States","volume":"356","author":"Ravdin","year":"2007","journal-title":"Oestradiol NEJM"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/jfprhc-2012-100508","article-title":"Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies. Part 5. Secular trends","volume":"39","author":"Shapiro","year":"2013","journal-title":"J.\u00a0Fam. Plan. Reprod. Health Care"},{"issue":"5728","key":"10.1016\/j.atherosclerosis.2016.10.005_bib21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.1112062","article-title":"Molecular and cellular basis of cardiovascular gender differences","volume":"308","author":"Mendelsohn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0008-6363(99)00153-4","article-title":"Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system","volume":"43","author":"Post","year":"1999","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib23","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1641","article-title":"27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen","volume":"13","author":"Umetani","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.maturitas.2006.04.012","article-title":"Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation","volume":"55","author":"Eilertsen","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0925-4439(97)00097-5","article-title":"17\u03b2-Oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells","volume":"1406","author":"Wingrove","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2005.11.026","article-title":"Role of annexin II in estrogen-induced macrophage matrix metalloproteinase-9 activity: the modulating effect of statins","volume":"189","author":"Hwang","year":"2006","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.10.005_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1377\/hlthaff.2011.0892","article-title":"Even as mortality fell in most US counties, female mortality nonetheless rose in 42.8 percent of counties from 1992 to 2006","volume":"32","author":"Kindig","year":"2013","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib28","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/jgs.12140","article-title":"The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women, Part 1: comparison of therapeutic efficacy","volume":"61","author":"Hodis","year":"2013","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib29","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/GME.0000000000000450","article-title":"Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality","volume":"22","author":"Mikkola","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/AOG.0000000000000461","article-title":"Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative","volume":"124","author":"Tuomikoski","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.maturitas.2015.04.002","article-title":"The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: a cohort study","volume":"81","author":"Tuomikoski","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/humrep\/dew014","article-title":"Vaginal estradiol use and the risk for cardiovascular mortality","volume":"31","author":"Mikkola","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/GME.0000000000000354","volume":"22","author":"Carrasquilla","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0033-0620(95)80012-3","article-title":"The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women","volume":"38","author":"Grodstein","year":"1995","journal-title":"Prog. Cardiol. Dis."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5122(98)00055-3","article-title":"Estrogen for women at varying risk of coronary disease","volume":"30","author":"Grodstein","year":"1998","journal-title":"Maturitas"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.brainres.2010.10.076","article-title":"A\u00a0window of opportunity: the reduction of coronary heart disease and total mortality with menopausal therapies is age and time dependent","volume":"1379","author":"Hodis","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib37","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1136\/bmj.e6409","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomized trial","volume":"345","author":"Schierbeck","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib38","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":"Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative","volume":"166","author":"Hsia","year":"2006","journal-title":"Arch. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib40","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1497.2006.00389.x","article-title":"Brief report: coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis","volume":"21","author":"Salpeter","year":"2006","journal-title":"J.\u00a0Gen. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1525-1497.2004.30281.x","article-title":"Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis","volume":"19","author":"Salpeter","year":"2004","journal-title":"J.\u00a0Gen. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002229.pub4","article-title":"Hormone therapy for preventing cardiovascular disease in postmenopausal women","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib44","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.amjmed.2009.05.021","article-title":"Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women","volume":"122","author":"Salpeter","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0021-9150(00)00372-5","article-title":"Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women","volume":"153","author":"Tremollieres","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib46","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.maturitas.2004.01.003","article-title":"Long-term hormone replacement therapy delays the age related progression of carotid intima-media thickness in healthy postmenopausal women","volume":"49","author":"Takahashi","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib47","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1161\/01.ATV.18.7.1149","article-title":"Age-related deterioration in arterial structure and function in postmenopausal women: impact of hormone replacement therapy","volume":"18","author":"McGrath","year":"1998","journal-title":"Arter. Thromb. Vas Biol."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0378-5122(99)00035-3","article-title":"Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness","volume":"32","author":"de Kleijn","year":"1999","journal-title":"Maturitas"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib49","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/oxfordjournals.aje.a117553","article-title":"Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women","volume":"142","author":"Espeland","year":"1995","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib50","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-135-11-200112040-00005","article-title":"Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial","volume":"135","author":"Hodis","year":"2001","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/M14-0353","article-title":"Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial","volume":"161","author":"Harman","year":"2014","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib52","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2265.2007.02772.x","article-title":"A\u00a0dose-response study of hormone replacement in young hypogonadal women: effects on intima-media thickness and metabolism","volume":"66","author":"Osteberg","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib53","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1505241","article-title":"Effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib54","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1210\/jc.2003-031008","article-title":"Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women","volume":"88","author":"Akhrass","year":"2003","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00042192-200512010-00009","article-title":"Hormone therapy and coronary artery calcification in asymptomatic postmenopausal women: the Rancho Bernardo Study","volume":"12","author":"Barrett-Connor","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/152460902760360577","article-title":"The association of hormone replacement therapy and coronary calcium as determined by electron beam tomography","volume":"11","author":"Schisterman","year":"2002","journal-title":"J.\u00a0Womens Health Gend. Based Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib57","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","article-title":"Estrogen therapy and coronary-artery calcification","volume":"356","author":"Manson","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib58","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1001\/jama.291.18.2243","article-title":"Drug treatment of hyperlipidemia in women","volume":"291","author":"Walsh","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2008.08.001","article-title":"Impact of gender in primary prevention of coronary heart disease with stain therapy: a meta-analysis","volume":"138","author":"Petretta","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib60","doi-asserted-by":"crossref","first-page":"b2376","DOI":"10.1136\/bmj.b2376","article-title":"The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomized controlled trials","volume":"338","author":"Brugts","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib61","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib62","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A\u00a0randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib63","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial","volume":"300","author":"Ogawa","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib64","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa021716","article-title":"A\u00a0comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly","volume":"348","author":"Wing","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib65","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0735-1097(03)00262-6","article-title":"Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials","volume":"41","author":"Shekelle","year":"2003","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib66","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","author":"Yusuf","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.amjmed.2008.07.026","article-title":"The cost-effectiveness of hormone therapy in younger and older postmenopausal women","volume":"122","author":"Salpeter","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib68","first-page":"e1","article-title":"Duration of menopausal vasomotor symptoms over the menopause transition","author":"Avis","year":"2014","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib69","first-page":"461","article-title":"Effect of hormone therapy on the risk of bone fractures: a systematic review and meta-analysis of randomized controlled trials","volume":"4","author":"Zhu","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib70","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bone.2003.12.021","article-title":"Two to three years of hormone replacement treatment in healthy women have long term preventive effects on bone mass and osteoporotic fractures:the PERF Study","volume":"34","author":"Bagger","year":"2004","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.10.005_bib71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00042192-200512010-00005","article-title":"Early postmenopausal hormone therapy may prevent cognitive impairment later in life","volume":"12","author":"Bagger","year":"2005","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.10.005_bib72","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/GME.0000000000000611","article-title":"Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri and postmenopausal women and in relation to type and route of administration","volume":"23","author":"Bergendal","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib73","unstructured":"https:\/\/www.asc.org\/irs\/statinfo\/."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib74","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.39440.525752.BE","article-title":"Vascular events in healthy older women receiving calcium supplementation: randomized controlled trial","volume":"336","author":"Bolland","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib75","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jamainternmed.2013.9071","article-title":"Use of antihypertensive medications and breast Cancer risk among women aged 55 to 74 years","volume":"173","author":"Li","year":"2013","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib76","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in Type 2 Diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib77","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen and progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib78","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1470-2045(12)70075-X","article-title":"Conjugated equine estrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomized placebo-controlled trial","volume":"13","author":"Anderson","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib79","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib80","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.166.9.1027","article-title":"Unopposed estrogen therapy and the risk of invasive breast cancer","volume":"166","author":"Chen","year":"2006","journal-title":"Arch. Intern Med."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/13697137.2012.666456","article-title":"Hormone therapy and breast cancer risk 10 years after the WHI","volume":"15","author":"Gompel","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib82","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib83","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00042192-200011000-00005","article-title":"Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women","volume":"7","author":"Davis","year":"2000","journal-title":"Menopause"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.steroids.2014.06.004","article-title":"Development of conjugated estrogens\/bazedoxifene, the first tissue selective estrogen complex (TSEC) for 7:e3411 management of menopausal hot flashes and postmenopausal bone loss","volume":"90","author":"Komm","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib85","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among postme3nopausal women: impact of the route of administration and progestogens: the ESTER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2016.10.005_bib86","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMp1514242","article-title":"Menopause management \u2013 getting clinical care back on track","volume":"374","author":"Manson","year":"2016","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016314083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016314083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T17:13:17Z","timestamp":1718817197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016314083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":86,"alternative-id":["S0021915016314083"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.10.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726855578.793563976","asserted-by":"object"}]},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}